These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3488420)

  • 1. Radiolabeled ligands expand PET exploration of numerous normal, abnormal brain functions.
    Riesenberg D
    JAMA; 1986 Aug 22-29; 256(8):969-70. PubMed ID: 3488420
    [No Abstract]   [Full Text] [Related]  

  • 2. Imaging of neurotransmitter receptors in the living human brain.
    Sedvall G; Farde L; Persson A; Wiesel FA
    Arch Gen Psychiatry; 1986 Oct; 43(10):995-1005. PubMed ID: 3019270
    [No Abstract]   [Full Text] [Related]  

  • 3. In vivo imaging of neurotransmitter systems using radiolabeled receptor ligands.
    Kegeles LS; Mann JJ
    Neuropsychopharmacology; 1997 Nov; 17(5):293-307. PubMed ID: 9348545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiolabeled ligands for imaging the muscarinic-cholinergic receptors of the heart and brain.
    Knapp FF; McPherson DW; Luo H; Zeeburg B
    Anticancer Res; 1997; 17(3B):1559-72. PubMed ID: 9179195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligands for imaging opioid receptors in conscious humans by positron emission tomography (PET).
    Newman A; Channing M; Finn R; Dunn B; Simpson N; Carson R; Ostrowski N; Cohen R; Burke T; Larson S
    NIDA Res Monogr; 1988; 90():117-21. PubMed ID: 2855850
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of two PET radioligands for imaging extrastriatal dopamine receptors in the human brain.
    Wang GJ; Volkow ND; Fowler JS; Wolf AP; MacGregor RR; Shea CE; Schlyer DJ; Hitzemann RJ
    Synapse; 1993 Nov; 15(3):246-9. PubMed ID: 8278901
    [No Abstract]   [Full Text] [Related]  

  • 7. A reawakening of interest in radionuclide brain imaging.
    Holmes RA
    J Nucl Med; 1986 Feb; 27(2):299-301. PubMed ID: 3486952
    [No Abstract]   [Full Text] [Related]  

  • 8. Development of a new radioligand, N-(5-fluoro-2-phenoxyphenyl)-N-(2-[18F]fluoroethyl-5-methoxybenzyl)acetamide, for pet imaging of peripheral benzodiazepine receptor in primate brain.
    Zhang MR; Maeda J; Ogawa M; Noguchi J; Ito T; Yoshida Y; Okauchi T; Obayashi S; Suhara T; Suzuki K
    J Med Chem; 2004 Apr; 47(9):2228-35. PubMed ID: 15084121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization of radioligands in schizophrenia research.
    Sedvall G; Farde L; Hall H; Halldin C; Karlsson P; Nordström AL; Nyberg S; Pauli S
    Clin Neurosci; 1995; 3(2):112-21. PubMed ID: 7583617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of positron emission tomography ligands for NPY Y5 receptors in the brain.
    Takahashi H; Haga Y; Shibata T; Nonoshita K; Sakamoto T; Moriya M; Ohe T; Chiba M; Mitobe Y; Kitazawa H; Iwaasa H; Ishihara A; Ishii Y; Kanatani A; Fukami T
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5436-9. PubMed ID: 19679469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Present and future capabilities of molecular imaging techniques to understand brain function.
    Jones T
    J Psychopharmacol; 1999 Dec; 13(4):324-9. PubMed ID: 10667607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N,N-dimethyl-2-(2-amino-4-(18)F-fluorophenylthio)-benzylamine (4-(18)F-ADAM): an improved PET radioligand for serotonin transporters.
    Shiue GG; Choi SR; Fang P; Hou C; Acton PD; Cardi C; Saffer JR; Greenberg JH; Karp JS; Kung HF; Shiue CY
    J Nucl Med; 2003 Dec; 44(12):1890-7. PubMed ID: 14660713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altropane, a SPECT or PET imaging probe for dopamine neurons: III. Human dopamine transporter in postmortem normal and Parkinson's diseased brain.
    Madras BK; Gracz LM; Fahey MA; Elmaleh D; Meltzer PC; Liang AY; Stopa EG; Babich J; Fischman AJ
    Synapse; 1998 Jun; 29(2):116-27. PubMed ID: 9593102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine receptor classification, neuroanatomical distribution and in vivo imaging.
    Brücke T; Wenger S; Podreka I; Asenbaum S
    Wien Klin Wochenschr; 1991; 103(21):639-46. PubMed ID: 1771898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of PET ligands (+)N-[(11)C]ethyl-3-piperidyl benzilate and (+)N-[(11)C]propyl-3-piperidyl benzilate for muscarinic cholinergic receptors: a PET study with microdialysis in comparison with (+)N-[(11)C]methyl-3-piperidyl benzilate in the conscious monkey brain.
    Nishiyama S; Tsukada H; Sato K; Kakiuchi T; Ohba H; Harada N; Takahashi K
    Synapse; 2001 Jun; 40(3):159-69. PubMed ID: 11304753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Derivatives of 4,6-diamino-1,2-dihydro-2-phenyl-1,2,4-triazolo[4,3-a]quinoxalin-2H-1-one: potential antagonist ligands for imaging the A2A adenosine receptor by positron emission tomography (PET).
    Holschbach MH; Bier D; Wutz W; Sihver W; Schüller M; Olsson RA
    Eur J Med Chem; 2005 May; 40(5):421-37. PubMed ID: 15893016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graphical analysis of 2-[18F]FA binding to nicotinic acetylcholine receptors in rhesus monkey brain.
    Chefer SI; London ED; Koren AO; Pavlova OA; Kurian V; Kimes AS; Horti AG; Mukhin AG
    Synapse; 2003 Apr; 48(1):25-34. PubMed ID: 12557269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vivo imaging of benzodiazepine receptors of the central type].
    Bartenstein P; Schober O
    Wien Klin Wochenschr; 1991; 103(21):647-8. PubMed ID: 1663299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New receptor ligands for single-photon emission tomography of the brain].
    Schubiger PA
    Schweiz Med Wochenschr; 1992 Oct; 122(44):1678-88. PubMed ID: 1332190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a PET/SPECT agent for amyloid imaging in Alzheimer's disease.
    Wang Y; Klunk WE; Debnath ML; Huang GF; Holt DP; Shao L; Mathis CA
    J Mol Neurosci; 2004; 24(1):55-62. PubMed ID: 15314250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.